Back
Amicus Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
FOLD
Amicus Therapeutics
Last Price:
$9.83
Seasonality Move:
5.47%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.82 | Sell |
| 20-day SMA: | 9.84 | Sell |
| 50-day SMA: | 10.45 | Sell |
| 200-day SMA: | 10.64 | Sell |
| 8-day EMA: | 9.79 | Buy |
| 20-day EMA: | 9.9 | Sell |
| 50-day EMA: | 10.25 | Sell |
| 200-day EMA: | 10.81 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 45.87 | Sell |
| Chaikin Money Flow: | 1508811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.59 - 9.99) | Buy |
| Bollinger Bands (100): | (9.99 - 11.55) | Sell |
Amicus Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 9.80 while FOLD 8-day simple moving average is 9.82, which is a Sell signal.
-
The stock price of FOLD is 9.80 while Amicus Therapeutics 20-day SMA is 9.84, which makes it a Sell.
-
Amicus Therapeutics 50-day simple moving average is 10.45 while FOLD share price is 9.80, making it a Sell technically.
-
FOLD stock price is 9.80 and Amicus Therapeutics 200-day simple moving average is 10.64, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
44
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a SellThe current Amicus Therapeutics [FOLD] share price is $9.80. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2.9B
Price in USD:
9.80
Share Volume:
3.5M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Sell
44
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?The Amicus Therapeutics stock price is 9.80 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 9.80 while FOLD 8-day exponential moving average is 9.79, which is a Buy signal.
-
The stock price of FOLD is 9.80 while Amicus Therapeutics 20-day EMA is 9.90, which makes it a Sell.
-
Amicus Therapeutics 50-day exponential moving average is 10.25 while FOLD share price is 9.80, making it a Sell technically.
-
FOLD stock price is 9.80 and Amicus Therapeutics 200-day simple moving average is 10.81, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.19 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Amicus Therapeutics is a Sell
-
Amicus Therapeutics Relative Strength Index (RSI) is 45.87, which suggest Amicus Therapeutics is oversold
-
The Bollinger Bands (25) for Amicus Therapeutics is (9.59 - 9.99), which suggest Amicus Therapeutics is a Sell
-
The Bollinger Bands (100) for Amicus Therapeutics is (9.99 - 11.55), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.